跳至主要内容
临床试验/IRCT20210513051280N1
IRCT20210513051280N1尚未招募1 期

Assessment of safety and effectiveness of in utero infusion of menstrual blood stem cells in treatment of recurrent implantation failue: A double-blind phase 1 and 2 clinical trial

Iranian academic center for education culture and research0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 37 years(—)
性别
Female

入选标准

  • Women with recurrent implantation failure (Three unsuccessful embryo transfer cycles with transfer of at least one blast stage or one cleavage stage A in each cycle)
  • No history of previous pregnancy
  • FSH level of less than 10 mIU/mL
  • Negative results for HIV, HBS Ag, HCV and VDR

排除标准

  • Hydrosalpinx
  • Stage 3 or 4 endometriosis
  • Asherman's syndrome
  • Endometrial organic disease
  • Chromosomal abnormalities in parents
  • Spermogram abnormalities (DFI more than 30 and Normal sperm morphology less than 2%
  • PCO with metabolic syndrome
  • Anti-phospholipid antibodies
  • Autoimmune diseases including rheumatoid arthritis, thyroid autoimmunity, lupus
  • History of cancer, chemotherapy or radiotherapy
  • Thin endometrium
  • History of immunosuppressive drug intake during the past three months

研究者

发起方
Iranian academic center for education culture and research

相似试验